pep1
General Information
DRACP ID DRACP01760
Peptide Name pep1
Sequence EARPALLTSRLRFIPK
Sequence Length 16
UniProt ID O14746
PubChem CID Not available
Origin Not available
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
AsPC-1 | Pancreatic ductal adenocarcinoma | Carcinoma | Significantly inhibiting fibrosis of AsPC1 Cell | Xenograft experiments | Not available | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C85H146N26O21
Absent amino acids CDGHMNQVWY
Common amino acids LR
Mass 213598
Pl 12.22
Basic residues 4
Acidic residues 1
Hydrophobic residues 7
Net charge 3
Boman Index -3681
Hydrophobicity -20.63
Aliphatic Index 110
Half Life
Mammalian: 2.8 hour
Yeast: 10 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US2017/0028035A1
Patent Title Peptide Having Fibrosis Inhibitory Activity and Composition Containing Same
Other Iinformation Patent Application; Family: 14s / 14ex; Family Jurisdictions: CN, EP, US, JP, KR, WO; Legal Status: Active; Application No: 201515303370; Filed: Apr 10, 2015; Published: Feb 2, 2017; Earliest Priority: Apr 11, 2014; Granted: Apr 10, 2018
Other Published ID CN106456697A CN106456697B EP3130345A1 EP3130345A4 EP3130345B1 JP2017513941A JP2018193384A JP6420459B2 JP6748155B2 KR20160135358A US2018207241A1 US9937240B2 WO2015156649A1